Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • CAPA Plan - BSI CE Mark Closeout
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
      • R-TF-001-008 Label
      • R-TF-001-006 IFU and label validation
      • Promotional Materials
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
  • Pricing
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Information provided by the Manufacturer
  • R-TF-001-008 Label

R-TF-001-008 Label

Label​

  • Device name: Legit.Health Plus
  • European Medical Device Nomenclature (EMDN) coding: Z12040192 (General medicine diagnosis and monitoring instruments - Medical device software)
  • Global Medical Device Nomenclature (GMDN) coding: 65975
  • Risk Classification according to EU MDR 2017/745: Class IIb
  • Risk Classification according to Brasil RDC 751/2022: Class II
SymbolMeaningInformation
Unique Device Identification(01)8437025550005(10)1.1.0.0(11)YYYYMMDD
Version(10) 1.1.0.0
Manufacture date(11) 20260123
ManufacturerLegit.Health Legit.Health (AI Labs Group, SL) BAT Tower, Gran Vía 1, 48001, Bilbao, Biscay (Spain)
Authorised representative in BrazilBrasil Import Soluções para Saúde Ltda. Av. Cabore, N° 204-B, Sala 03 - Anexo Pousada Recanto dos Maddas, CEP 23970-000. Technical responsible: Claudia Carolina de Carvalho Mayer CRF/RJ 28.046
SymbolMeaning

eIFU
Consult electronic instructions for use
Caution

DRAFT
EU MDR 2017/745 CE marking (DRAFT)
Medical Device
ANVISARegistration # 81987060015
In case of observing an incorrect operation
In case of observing an incorrect operation of the software, notify the manufacturer as soon as possible: support@ legit.health. The manufacturer will proceed accordingly. Any serious incident related to the device must be reported both to the manufacturer and the competent authority in the Member State where the user or patient is located.
Undesirable side-effects
It is not known or foreseen any undesirable side-effects specifically related to the use of the software.

Labelling information, including eIFU URL, are included in the output json file, under the section device:

{
    "deviceName": "Legit.Health Plus",
    "description": "The device is a computational software-only medical device leveraging computer vision algorithms to process images of the epidermis, the dermis and its appendages, among other skin structures. Its principal function is to provide a wide range of clinical data from the analyzed images to assist healthcare practitioners in their clinical evaluations and allow healthcare provider organisations to gather data and improve their workflows.",
    "version": "1.1.0.0",
    "releaseDate": "2026-01-23",
    "manufacturer": {
        "name": "AI Labs Group S.L.",
        "description": "Digital health solutions developer specializing in AI-powered diagnostics",
        "countryCode": "ES",
        "website": "https://legit.health/"
    },
    "udi": "(01)00312345678901(17)251231(10)LOT123(21)SN9",
    "alternateIdentifiers": [
        {
            "system": "GMDN",
            "code": "65975",
            "issuingAuthority": "GMDN Agency",
            "description": "Global Medical Device Nomenclature identifier"
        },
        {
            "system": "EMDN",
            "code": "Z12040192",
            "issuingAuthority": null,
            "description": "European Medical Device Nomenclature code"
        }
    ],
    "standards": [
        {
            "standardName": "iso-14971",
            "standardVersion": "2019"
        },
        {
            "standardName": "iec-62304",
            "standardVersion": "2015"
        },
        {
            "standardName": "hl7-fhir",
            "standardVersion": "R5"
        }
    ],
    "regulatoryClearances": [
        {
            "regulation": "EU 2017/745",
            "riskClass": "Class IIb",
            "notifiedBody": "BSI Group (NB 2797)",
            "authorizationId": "CE-2024-12345",
            "authorizationDate": "2024-06-01"
        },
        {
            "regulation": "FDA",
            "riskClass": "Class II",
            "notifiedBody": null,
            "authorizationId": "K240001",
            "authorizationDate": "2024-08-15"
        }
    ],
    "claims": [
        {
            "description": "Users may request Instructions for Use in paper format at no additional cost within the EU territory.",
            "reference": "EU MDR 2017/745 Article 10(11)"
        },
        {
            "description": "30-day return policy for unused devices in original packaging.",
            "reference": "Internal Policy: RET-2024-001"
        }
    ],
    "contactEmail": "support@legit-health.com",
    "instructionsUrl": "https://apidocs-draft.legit.health/"
}

Signature meaning

The signatures for the approval process of this document can be found in the verified commits at the repository for the QMS. As a reference, the team members who are expected to participate in this document and their roles in the approval process, as defined in Annex I Responsibility Matrix of the GP-001, are:

  • Author: Team members involved
  • Reviewer: JD-003 Design & Development Manager, JD-004 Quality Manager & PRRC
  • Approver: JD-001 General Manager
ㅤ ㅤ

Previous
Information provided by the Manufacturer
Next
R-TF-001-006 IFU and label validation
  • Label
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)